At the West Michigan Rheumatology we pride ourselves in bringing patient centered, and research inspired care to West Michigan. Our rheumatology specialists work to understand your needs and circumstances in order to craft a treatment plan that helps place you in control. By focusing on both clinical services and research in one location, we’re making innovative rheumatic therapies within reach of West Michigan and the Lakeshore.
Regenerative Effects of Fat Derived Stem Cells in Scleroderma?
More than 90 percent of scleroderma patients have hand involvement, which is typically progressive with pain, blood flow changes, and severe loss of function.
WMR is collaborating with Cytori Therapeutics in conducting the STAR Trial, Phase III pivotal clinical trial of 80 patients with impaired hand function from scleroderma. The trial evaluates the one-year safety and effectiveness of a single administration of Cytori Cell Therapy: ECCS-50 in patients with scleroderma affecting the hands.
In a previously published trial, SCLERADEC I, conducted at Hospital de la Conception in France that demonstrated significant improvement in hand function, pain, and Raynaud’s severity in patients with scleroderma affecting the hands.
Introducing Eric Slavin, M.D.
Our physicians have served West Michigan for 25 years. We take this committment of service seriously and strive to meet our community’s needs.
To meet the growing need for high quality rheumatology consultation and care, we have have conducted a national search to attract a 5th rheumatologist to our practice.
Welcome to Grand Rapids, Eric!